Home »
Introduction
On this page we share the latest and most important internal and external updates with our members and the broader pharmaceutical medicine community.
We have collaborated with experts to produce a series of key blog articles which can be read below. These are scientifically rigorous, referenced and have undergone internal review.
We are also influencing policy, both independently and in collaboration with partner organisations, to ensure that best practice is adhered to in both clinical settings and in the ongoing search for treatments.
Page contents:
- How is FPM contributing to the efforts against the COVID-19 pandemic?
- FPM expert blog articles on the development of vaccines and therapeutics for COVID
- Information about COVID-19 vaccines and therapeutics
- How are COVID vaccines being used in the UK?
- Useful links
How is FPM contributing to the efforts against the COVID-19 pandemic?
FPM DEMENDE COVID-19 Workshop Report May 2022
Read the FPM DEMENDE COVID-19 Workshop Report and Recommendations, May 2022
We issue up-to-date guidance on how our members can volunteer to vaccinate
Our guidance includes first-hand experience on how pharmaceutical physicians have made themselves available to the NHS workforce.
We hosted an eight-webinar series looking at preparedness-planning for public health emergencies
These webinars were free to attend and are available to re-watch on demand.
We have scaled-up our public engagement via media appearances
Penny Ward appeared across numerous outlets including this feature on the BBC News website.
Additional media coverage was secured
Former chair of the PCG, Dr Gillies O'Bryan-Tear was prominent across many news outlets. FPM has received unprecedented media requests and our spokespersons have made contributions to the public discourse in UK and overseas media outlets.
We have issued re-active and pro-active policy statements on emerging developments
FPM put out a statement welcoming the increase in funding and expansion of the AGILE COVID-19 clinical trials platform.
We tapped into our members' experiences to produce a Clinical Trials Resilience Report
Aware that COVID-19 may have affected ongoing trials in other therapy areas, FPM surveyed its membership at the end of 2020 to gather their voices on these secondary effects of the pandemic.
FPM expert blog articles on the development of vaccines and therapeutics for COVID
Since the start of the COVID-19 pandemic FPM members and other guest authors have produced academically rigorous, internally-reviewed blog articles which have been widely read.
